Oxbryta (voxelotor) for the Treatment of Sickle Cell Disease

Image 1-Oxbryta (voxelotor)
Oxbryta™ (voxelotor) is a haemoglobin S polymerisation inhibitor indicated for the treatment of sickle cell disease. Credit: Global Blood Therapeutics, Inc.